Stephen E Sallan MD

Hematologic Oncology

Professor of Pediatrics, Dana-Farber Cancer Institute

450 Brookline AvenueRoom 1642Boston, MA 02215
Phone+1 617-632-3316
Fax+1 617-632-5511

Dr. Sallan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sallan's full profile Already have an account?

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1973 - 1975
Boston Children’s HospitalFellowship, Child and Adolescent Psychiatry, 1972 - 1973
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1968 - 1969
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1967 - 1968
Wayne State University School of MedicineClass of 1967

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1971 - 2027
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Pediatric Oncology Award American Society of Clinical Oncology, 2015
Boston Red Sox Biomedical All-Star 2003
Boston Magazine Castle Connolly, 2008-2013

Clinical Trials

Treatment of Childhood Acute Lymphoblastic Leukemia: Grant Application Title: Erwinia Asparaginase in Childhood Acute Leukemia Start of enrollment: 1996 Jan 01
Treatment of Childhood Acute Lymphoblastic Leukemia
TERMINATED
PHASE3

Publications & Presentations

PubMed

Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.
Melissa A Burns, Yael Flamand, Julia Keating, Victoria Koch, Sarah M Cronholm
Pediatric Blood & Cancer. 2026-10-01
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.
Rachid Abaji, Vincent Gagné, Émilie Espagne, Nathalie Alos, Veronica Del Vecchio
Clinical Pharmacology and Therapeutics. 2026-09-01
Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemia.
Steven E Lipshultz, Holly M Smith, Stephen E Sallan, Douglas B Sawyer
Cardio-Oncology. 2026-02-10

Abstracts/Posters

Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort
Stephen E. Sallan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

How I Treat Acute Lymphocytic Leukemia: Insight From the Experts
60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

Postinduction Dexamethasone and Individualized Dosing of Asparaginase Improve Outcome in Pediatric ALLJune 10th, 2013
Intensified Chemotherapy Shows Promise for Children with Very High Risk Form of LeukemiaDecember 10th, 2012
It Takes a Lifetime to Survive Childhood CancerOctober 17th, 2023

Grant Support

Clinical Consortia (Pediatric &Adult)National Cancer Institute2006–2010
Therapeutic Index Of Acute Lymphoblastic LeukemiaNational Cancer Institute2000–2010
Enhancing Treatment Outcomes In Childhood Acute Lymphocytic LeukemiaNational Cancer Institute2000–2002
Core--Acute Lymphocytic Leukemia ConsortiaNational Cancer Institute2000–2002
Fibroblast Growth Factor Quantification In ChildrenNational Center For Research Resources1996–2002